Ruane, Cunniff & Goldfarb Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Icon
ICLR
|
+$296M |
| 2 |
Elevance Health
ELV
|
+$58.3M |
| 3 |
Copa Holdings
CPA
|
+$242K |
| 4 |
Apple
AAPL
|
+$193K |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$27.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$188M |
| 2 |
Jacobs Solutions
J
|
+$183M |
| 3 |
CarMax
KMX
|
+$141M |
| 4 |
Capital One
COF
|
+$103M |
| 5 |
UnitedHealth
UNH
|
+$72.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 36.83% |
| 2 | Communication Services | 34.02% |
| 3 | Healthcare | 18.87% |
| 4 | Technology | 6.49% |
| 5 | Industrials | 3.67% |
Similar funds
Ruane, Cunniff & Goldfarb's Q4 2024 Portfolio in Review
As of Q4 2024, Ruane, Cunniff & Goldfarb held 40 positions worth $5.89B, down 7.9% from $6.39B the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Ruane, Cunniff & Goldfarb withdrew a net $603M in Q4 2024, closing 1 position and reducing 25 holdings. Its most notable exit was Micron Technology, an estimated $224K position sold in full.
By sector, the portfolio is most concentrated in Financials at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Healthcare.
Against the trend, Ruane, Cunniff & Goldfarb opened a new position in Icon worth $265M.
- Ruane, Cunniff & Goldfarb's largest Q4 2024 buy was Icon: 1,265,540 shares worth $265M.
- Ruane, Cunniff & Goldfarb added most to Elevance Health in Q4 2024, an estimated $58.3M increase.
- Ruane, Cunniff & Goldfarb's biggest Q4 2024 reduction was TSMC, cutting an estimated $188M.
- Ruane, Cunniff & Goldfarb fully exited Micron Technology in Q4 2024, selling an estimated $224K.
- Ruane, Cunniff & Goldfarb's ten largest holdings make up 76% of its $5.89B portfolio in Q4 2024.
- Ruane, Cunniff & Goldfarb opened 3 new positions and closed 1 in Q4 2024.
- Ruane, Cunniff & Goldfarb's portfolio value fell 7.9% quarter-over-quarter to $5.89B.
Based on Ruane, Cunniff & Goldfarb's 13F filing for Q4 2024, filed 14 Feb 2025.